UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031

Annals of oncology, 2011-02, Vol.22 (2), p.348-354

2011

Volltextzugriff (PDF)

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)

Annals of oncology, 2014-05, Vol.25 (5), p.1039-1044

2014

Volltextzugriff (PDF)

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)

Annals of oncology, 2019-02, Vol.30 (2), p.345-345

2019

Volltextzugriff (PDF)

The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia

Bone marrow transplantation (Basingstoke), 2011-02, Vol.46 (2), p.285-290

2011

Volltextzugriff (PDF)

Accuracy of self-reported tobacco use status among hematopoietic SCT patients

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.961-965

2014

Volltextzugriff (PDF)

Differential distribution of CCDC26 glioma-risk alleles in myeloid malignancies with mutant IDH1 compared with their IDH2R140-mutated or IDH-unmutated counterparts

Leukemia, 2012-06, Vol.26 (6), p.1406-1407

2012

Volltextzugriff (PDF)

Specific polysaccharide antibody deficiency syndrome (SPAD): Clinical and laboratory characteristics of seventy seven patients

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S158-S158

2005

Volltextzugriff (PDF)

Cessação tabágica em doentes com neoplasia do pulmão tratados para a dependência nicotínica

Revista portuguesa de pneumologia, 2003-01, Vol.9 (1), p.83-85

2003

Volltextzugriff (PDF)

CessaÃ§Ã£o tabÃ¡gica em doentes com neoplasia do pulmÃ£o tratados para a dependÃªncia nicotÃnica

Revista portuguesa de pneumologia, 2003-01, Vol.9 (1), p.83-85

2003

Volltextzugriff (PDF)

Effects of four treatment strategies for temporomandibular joint closed lock

International journal of oral and maxillofacial surgery, 2014-02, Vol.43 (2), p.217-226

2014

Volltextzugriff (PDF)

Ligand-Based Phase Control in Porous Zirconium Coordination Cages

Chemistry of materials, 2020-07, Vol.32 (13), p.5872-5878

2020

Volltextzugriff (PDF)

Identification and evaluation of risk of generalizability biases in pilot versus efficacy/effectiveness trials: a systematic review and meta-analysis

The international journal of behavioral nutrition and physical activity, 2020-02, Vol.17 (1), p.19-19, Article 19

2020

Volltextzugriff (PDF)

A Charged Coordination Cage-Based Porous Salt

Journal of the American Chemical Society, 2020-05, Vol.142 (21), p.9594-9598

2020

Volltextzugriff (PDF)

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Annals of oncology, 2023-08, Vol.34 (8), p.660-669

2023

Volltextzugriff (PDF)

350MO Omission of chemotherapy and addition of the CDK4/6 inhibitor ribociclib in HER2-positive and hormone-receptor positive metastatic breast cancer – Second interim efficacy analysis of the randomized phase III DETECT V trial

Annals of oncology, 2024-09, Vol.35, p.S362-S362

2024

Volltextzugriff (PDF)

269P Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry

Annals of oncology, 2022-09, Vol.33, p.S660

2022

Volltextzugriff (PDF)

247P Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptor–positive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study

Annals of oncology, 2021-09, Vol.32, p.S467-S468

2021

Volltextzugriff (PDF)

LBA19 A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (mBC) (DESIREE)

Annals of oncology, 2021-09, Vol.32, p.S1292-S1293

2021

Volltextzugriff (PDF)

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

Annals of oncology, 2014-12, Vol.25 (12), p.2363-2372

2014

Volltextzugriff (PDF)

Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer

Current oncology (Toronto), 2017-04, Vol.24 (2), p.81-89

2017

Volltextzugriff (PDF)

Real-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study

Annals of oncology, 2018-10, Vol.29, p.viii89-viii89

2018

Volltextzugriff (PDF)

PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Annals of oncology, 2019-10, Vol.30, p.v142

2019

Volltextzugriff (PDF)

389TiP - PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Annals of oncology, 2019-10, Vol.30, p.v142-v142

2019

Volltextzugriff (PDF)

Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system

European journal of cancer (1990), 2020-10, Vol.138, p.S68-S68

2020

Volltextzugriff (PDF)

A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)

ESMO open, 2022-12, Vol.7 (6), p.100601, Article 100601

2022

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(45)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(17)
Humans
(12)
Oncology
(10)
Female
(8)
Middle Aged
(8)
Adult
(7)
Biological And Medical Sciences
(6)
Treatment Outcome
(6)
Aged
(5)
Male
(5)
Medical Sciences
(5)
Original
(5)
Surgery
(5)
Tumors
(4)
Antineoplastic Agents
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Hematology
(3)
Hematology, Oncology And Palliative Medicine
(3)
Immunology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)

The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia

Accuracy of self-reported tobacco use status among hematopoietic SCT patients

Differential distribution of CCDC26 glioma-risk alleles in myeloid malignancies with mutant IDH1 compared with their IDH2R140-mutated or IDH-unmutated counterparts

Specific polysaccharide antibody deficiency syndrome (SPAD): Clinical and laboratory characteristics of seventy seven patients

Cessação tabágica em doentes com neoplasia do pulmão tratados para a dependência nicotínica

CessaÃ§Ã£o tabÃ¡gica em doentes com neoplasia do pulmÃ£o tratados para a dependÃªncia nicotÃnica

Effects of four treatment strategies for temporomandibular joint closed lock

Ligand-Based Phase Control in Porous Zirconium Coordination Cages

Identification and evaluation of risk of generalizability biases in pilot versus efficacy/effectiveness trials: a systematic review and meta-analysis

A Charged Coordination Cage-Based Porous Salt

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

350MO Omission of chemotherapy and addition of the CDK4/6 inhibitor ribociclib in HER2-positive and hormone-receptor positive metastatic breast cancer – Second interim efficacy analysis of the randomized phase III DETECT V trial

269P Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry

247P Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptor–positive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study

LBA19 A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (mBC) (DESIREE)

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer

Real-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study

PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

389TiP - PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system

A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)

Suchergebnisse filtern